193 related articles for article (PubMed ID: 33045575)
21. Th17 cells and IL-17 promote the skin and lung inflammation and fibrosis process in a bleomycin-induced murine model of systemic sclerosis.
Lei L; Zhao C; Qin F; He ZY; Wang X; Zhong XN
Clin Exp Rheumatol; 2016; 34 Suppl 100(5):14-22. PubMed ID: 26750756
[TBL] [Abstract][Full Text] [Related]
22. The effect of melatonin on bleomycin-induced pulmonary fibrosis in rats.
Arslan SO; Zerin M; Vural H; Coskun A
J Pineal Res; 2002 Jan; 32(1):21-5. PubMed ID: 11841596
[TBL] [Abstract][Full Text] [Related]
23. Protective Effect of Tunisian Flaxseed Oil against Bleomycin-Induced Pulmonary Fibrosis in Rats.
Abidi A; Kourda N; Feki M; Ben Khamsa S
Nutr Cancer; 2020; 72(2):226-238. PubMed ID: 31155950
[TBL] [Abstract][Full Text] [Related]
24. Ajulemic acid exerts potent anti-fibrotic effect during the fibrogenic phase of bleomycin lung.
Lucattelli M; Fineschi S; Selvi E; Garcia Gonzalez E; Bartalesi B; De Cunto G; Lorenzini S; Galeazzi M; Lungarella G
Respir Res; 2016 May; 17(1):49. PubMed ID: 27153807
[TBL] [Abstract][Full Text] [Related]
25. Uridine supplementation exerts anti-inflammatory and anti-fibrotic effects in an animal model of pulmonary fibrosis.
Cicko S; Grimm M; Ayata K; Beckert J; Meyer A; Hossfeld M; Zissel G; Idzko M; Müller T
Respir Res; 2015 Sep; 16(1):105. PubMed ID: 26369416
[TBL] [Abstract][Full Text] [Related]
26. Naja naja atra venom ameliorates pulmonary fibrosis by inhibiting inflammatory response and oxidative stress.
Cui K; Kou JQ; Gu JH; Han R; Wang G; Zhen X; Qin ZH
BMC Complement Altern Med; 2014 Dec; 14():461. PubMed ID: 25465226
[TBL] [Abstract][Full Text] [Related]
27. Use of tetrandrine to differentiate between mechanisms involved in silica-versus bleomycin-induced fibrosis.
Ma JY; Barger MW; Hubbs AF; Castranova V; Weber SL; Ma JK
J Toxicol Environ Health A; 1999 Jun; 57(4):247-66. PubMed ID: 10406349
[TBL] [Abstract][Full Text] [Related]
28. Exogenous nitric oxide enhances the prophylactic effect of aminoguanidine, a preferred iNOS inhibitor, on bleomycin-induced fibrosis in the lung: Implications for the direct roles of the NO molecule in vivo.
Chen C; Yun XJ; Liu LZ; Guo H; Liu LF; Chen XL
Nitric Oxide; 2017 Nov; 70():31-41. PubMed ID: 28757441
[TBL] [Abstract][Full Text] [Related]
29. Preventive Effects of Rhodiola rosea L. on Bleomycin-Induced Pulmonary Fibrosis in Rats.
Zhang K; Si XP; Huang J; Han J; Liang X; Xu XB; Wang YT; Li GY; Wang HY; Wang JH
Int J Mol Sci; 2016 Jun; 17(6):. PubMed ID: 27271612
[TBL] [Abstract][Full Text] [Related]
30. In vivo antioxidant treatment protects against bleomycin-induced lung damage in rats.
Serrano-Mollar A; Closa D; Prats N; Blesa S; Martinez-Losa M; Cortijo J; Estrela JM; Morcillo EJ; Bulbena O
Br J Pharmacol; 2003 Mar; 138(6):1037-48. PubMed ID: 12684259
[TBL] [Abstract][Full Text] [Related]
31. Prevention of bleomycin-induced lung inflammation and fibrosis in mice by naproxen and JNJ7777120 treatment.
Rosa AC; Pini A; Lucarini L; Lanzi C; Veglia E; Thurmond RL; Stark H; Masini E
J Pharmacol Exp Ther; 2014 Nov; 351(2):308-16. PubMed ID: 25185215
[TBL] [Abstract][Full Text] [Related]
32. Alleviation of remote lung injury following liver ischemia/reperfusion: Possible protective role of vildagliptin.
Sherif IO; Al-Shaalan NH
Int Immunopharmacol; 2021 Feb; 91():107305. PubMed ID: 33388732
[TBL] [Abstract][Full Text] [Related]
33. Protective and anti-inflammatory effect of selenium nano-particles against bleomycin-induced pulmonary injury in male rats.
Shahabi R; Anissian A; Javadmoosavi SA; Nasirinezhad F
Drug Chem Toxicol; 2021 Jan; 44(1):92-100. PubMed ID: 31146593
[TBL] [Abstract][Full Text] [Related]
34. Amitriptyline attenuates bleomycin-induced pulmonary fibrosis: modulation of the expression of NF-κβ, iNOS, and Nrf2.
Zaafan MA; Haridy AR; Abdelhamid AM
Naunyn Schmiedebergs Arch Pharmacol; 2019 Mar; 392(3):279-286. PubMed ID: 30474696
[TBL] [Abstract][Full Text] [Related]
35. Adhatoda Vasica attenuates inflammatory and hypoxic responses in preclinical mouse models: potential for repurposing in COVID-19-like conditions.
Gheware A; Dholakia D; Kannan S; Panda L; Rani R; Pattnaik BR; Jain V; Parekh Y; Enayathullah MG; Bokara KK; Subramanian V; Mukerji M; Agrawal A; Prasher B
Respir Res; 2021 Apr; 22(1):99. PubMed ID: 33823870
[TBL] [Abstract][Full Text] [Related]
36. Pirfenidone protects against paraquat-induced lung injury and fibrosis in mice by modulation of inflammation, oxidative stress, and gene expression.
Pourgholamhossein F; Rasooli R; Pournamdari M; Pourgholi L; Samareh-Fekri M; Ghazi-Khansari M; Iranpour M; Poursalehi HR; Heidari MR; Mandegary A
Food Chem Toxicol; 2018 Feb; 112():39-46. PubMed ID: 29273418
[TBL] [Abstract][Full Text] [Related]
37. Sinapic acid ameliorates bleomycin-induced lung fibrosis in rats.
Raish M; Ahmad A; Ahmad Ansari M; Ahad A; Al-Jenoobi FI; Al-Mohizea AM; Khan A; Ali N
Biomed Pharmacother; 2018 Dec; 108():224-231. PubMed ID: 30219680
[TBL] [Abstract][Full Text] [Related]
38. A further investigation concerning correlation between anti-fibrotic effect of liposomal quercetin and inflammatory cytokines in pulmonary fibrosis.
Baowen Q; Yulin Z; Xin W; Wenjing X; Hao Z; Zhizhi C; Xingmei D; Xia Z; Yuquan W; Lijuan C
Eur J Pharmacol; 2010 Sep; 642(1-3):134-9. PubMed ID: 20510684
[TBL] [Abstract][Full Text] [Related]
39. Protective effects of microbial biosurfactants produced by Bacillus halotolerans and Candida parapsilosis on bleomycin-induced pulmonary fibrosis in mice: Impact of antioxidant, anti-inflammatory and anti-fibrotic properties via TGF-β1/Smad-3 pathway and miRNA-326.
Mousa AM; Nooman MU; Abbas SS; Gebril SM; Abdelraof M; Al-Kashef AS
Toxicol Appl Pharmacol; 2024 May; 486():116939. PubMed ID: 38643951
[TBL] [Abstract][Full Text] [Related]
40. Protective effects of GHK-Cu in bleomycin-induced pulmonary fibrosis via anti-oxidative stress and anti-inflammation pathways.
Ma WH; Li M; Ma HF; Li W; Liu L; Yin Y; Zhou XM; Hou G
Life Sci; 2020 Jan; 241():117139. PubMed ID: 31809714
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
